Search Results

Filter
  • 1-10 of  183,847 results for ""INTERFERON alpha""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Construction of viral-based expression vectors for high-level production of human interferon alpha 2b in plants.

  • Authors : Sindarovska Y; Department of Genetic Engineering, Institute of Cell Biology and Genetic Engineering of NAS of Ukraine, Akad. Zabolotnogo Str., 148, Kyiv, 03148, Ukraine. .; Kuchuk M

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/metabolism ; Genetic Vectors*

  • Source: Applied microbiology and biotechnology [Appl Microbiol Biotechnol] 2024 Feb 23; Vol. 108 (1), pp. 229. Date of Electronic Publication: 2024 Feb 23.Publisher: Springer International Country of Publication: Germany NLM ID: 8406612 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Detection of interferon alpha and beta receptor subunit 1 (IFNAR1) loss-of-function Glu386∗ variant by tri-allelic genotyping.

  • Authors : Woon ST; Molecular Immunology, LabPLUS, Te Whatu Ora, Health New Zealand Te Toka Tumai Auckland, New Zealand; Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Electronic address: .

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Receptor, Interferon alpha-beta*/Receptor, Interferon alpha-beta*/Receptor, Interferon alpha-beta*/genetics; Humans

  • Source: Pathology [Pathology] 2024 Feb; Vol. 56 (1), pp. 92-97. Date of Electronic Publication: 2023 Oct 29.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 0175411 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Inhibition of human cytomegalovirus replication by interferon alpha can involve multiple anti-viral factors.

  • Authors : Chowdhury S; Institute of Infection & Immunity, St George's, University of London, London, UK.; Latham KA

Subjects: Cytomegalovirus*/Cytomegalovirus*/Cytomegalovirus*/physiology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology; Humans

  • Source: The Journal of general virology [J Gen Virol] 2023 Dec; Vol. 104 (12).Publisher: Microbiology Society Country of Publication: England NLM ID: 0077340 Publication Model: Print Cited Medium: Internet ISSN: 1465-2099

Record details

×
Academic Journal

Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.

  • Authors : Irani YD; Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; The University of Adelaide, School of Medicine, Adelaide, South Australia, Australia.

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy; Humans

  • Source: British journal of haematology [Br J Haematol] 2023 Sep; Vol. 202 (6), pp. 1127-1136. Date of Electronic Publication: 2023 Jul 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; HIV-1*/HIV-1*/HIV-1*/genetics ; Panobinostat*/Panobinostat*/Panobinostat*/therapeutic use

  • Source: Cell [Cell] 2024 Feb 29; Vol. 187 (5), pp. 1238-1254.e14. Date of Electronic Publication: 2024 Feb 17.Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

CD8+ Lymphocytes from Healthy Blood Donors Secrete Antiviral Levels of Interferon-Alpha.

  • Authors : Teque F; Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.; Wegehaupt A

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/metabolism ; HIV Infections*; Humans

  • Source: Viruses [Viruses] 2023 Mar 30; Vol. 15 (4). Date of Electronic Publication: 2023 Mar 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

×
Academic Journal

Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/adverse effects ; Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/Leukemia, Myeloid, Chronic-Phase*/drug therapy; Humans

  • Source: British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (2), pp. 175-186. Date of Electronic Publication: 2022 Oct 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis.

  • Authors : Buchynskyi M; Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.; Kamyshna I

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19* ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use

  • Source: Frontiers in immunology [Front Immunol] 2023 Jan 26; Vol. 14, pp. 1069894. Date of Electronic Publication: 2023 Jan 26 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

[Progress in the clinical cure of the population of inactive hepatitis B surface antigen carriers].

  • Authors : Mo ZS; Department of Infectious Diseases, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.; Gao ZL

Subjects: Hepatitis B Surface Antigens* ; Interferon-alpha*

  • Source: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology [Zhonghua Gan Zang Bing Za Zhi] 2023 Dec 20; Vol. 31 (12), pp. 1336-1339.Publisher: Chongqing yi ke da xue, di 2 lin chuang xue yuan Bing du xing gan yan yan jiu suo Country of Publication: China NLM ID: 9710009 Publication Model:

Record details

×
Academic Journal

[Interferon-α mediating the functional damage of CD56 dim CD57 + natural killer cells in peripheral blood of systemic lupus erythematosuss].

  • Authors : Zhao XG; Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian 116044, Liaoning, China.; Liu JQ

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/metabolism ; Lupus Erythematosus, Systemic*

  • Source: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences [Beijing Da Xue Xue Bao Yi Xue Ban] 2023 Dec 18; Vol. 55 (6), pp. 975-981.Publisher: Beijing da xue Country of Publication: China NLM ID: 101125284 Publication Model: Print Cited Medium: Print ISSN: 1671-167X (Print)

Record details

×
  • 1-10 of  183,847 results for ""INTERFERON alpha""